Fair Value Measurements (Tables)
|
6 Months Ended |
Jun. 30, 2024 |
Fair Value Disclosures [Abstract] |
|
Schedule Of Assets And Liabilities Measured At Fair Value On A Recurring Basis |
The following table summarizes the Company’s assets and liabilities that are measured at fair value on a recurring basis as required by ASC 820, by level, within the fair value hierarchy as of June 30, 2024 and December 31, 2023 (in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
June 30, 2024 |
|
Fair Value |
|
Level 1 |
|
Level 2 |
|
Level 3 |
Liability |
|
|
|
|
|
|
|
Contingent earnout shares liability |
$ |
— |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
— |
|
Derivative liability, current |
$ |
— |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
— |
|
Convertible debt, current |
$ |
47,228 |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
47,228 |
|
Derivative liability, non-current |
$ |
33,242 |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
33,242 |
|
Warrant liability, non-current |
$ |
55,995 |
|
|
$ |
— |
|
|
$ |
55,995 |
|
|
$ |
— |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 2023 |
|
Fair Value |
|
Level 1 |
|
Level 2 |
|
Level 3 |
Liability |
|
|
|
|
|
|
|
Contingent earnout shares liability |
$ |
41 |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
41 |
|
Derivative liability, current |
$ |
860 |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
860 |
|
Convertible debt, current |
$ |
16,052 |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
16,052 |
|
Derivative liability, non-current |
$ |
25,919 |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
25,919 |
|
Warrant liability, non-current |
$ |
17,390 |
|
|
$ |
— |
|
|
$ |
17,390 |
|
|
$ |
— |
|
|
Schedule of Fair Value of the Initial Loans Based on Assumptions |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Tenth Pre-Paid Advance |
June Prepaid Advance |
|
|
|
|
Stock price |
|
$ |
2.13 |
|
$ |
2.13 |
|
Risk free interest rate |
|
5.4 |
% |
5.3 |
% |
Interest rate |
|
5.0 |
% |
5.0 |
% |
Expected volatility |
|
116.7 |
% |
144.0 |
% |
Expected dividend yield |
|
— |
% |
— |
% |
Remaining term (in years) |
|
0.2 |
0.5 |
The following table summarizes the Company’s stock-based compensation expense by line item for the three and six months ended June 30, 2024 and 2023 (in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three months ended
June 30,
|
|
Six months ended June 30, |
|
2024 |
|
2023 |
|
2024 |
|
2023 |
Research and development |
$ |
(680) |
|
|
$ |
209 |
|
|
$ |
(50) |
|
|
$ |
4,344 |
|
Selling, general and administrative |
1,808 |
|
|
6,498 |
|
12,132 |
|
|
12,199 |
Total |
$ |
1,128 |
|
|
$ |
6,707 |
|
|
$ |
12,082 |
|
|
$ |
16,543 |
|
The key inputs used in the valuation were as follows:
|
|
|
|
|
|
|
|
Expected term (years) |
10.0 |
Risk free interest rate |
3.0 |
% |
Expected volatility |
91.3 |
% |
Dividend yield |
— |
% |
Exercise price |
$ |
49.45 |
|
Stock price |
$ |
83.49 |
|
The key inputs used in the valuation were as follows:
|
|
|
|
|
|
|
|
Expected term (year) |
4.7 |
Expected volatility |
117.5 |
% |
Dividend yield |
— |
% |
Risk free rate |
4.3 |
% |
Estimated fair value per warrant |
$ |
1.82 |
|
Exercise price |
$ |
1.37 |
|
Stock price |
$ |
2.13 |
|
The key inputs used in the valuation were as follows:
|
|
|
|
|
|
|
|
Expected term (years) |
4.1 |
Expected volatility |
117.5 |
% |
Expected dividend rate |
— |
% |
Risk free rate |
4.4 |
% |
Estimated fair value per warrant |
$ |
0.87 |
|
Exercise price |
$ |
29.90 |
|
Stock price |
$ |
2.13 |
|
The key inputs used in the valuation were as follows:
|
|
|
|
|
|
Expected term (years) |
4.5 |
Expected volatility |
117.5 |
% |
Expected dividend rate |
— |
% |
Risk free rate |
4.3 |
% |
Estimated fair value per warrant |
$1.18 |
Exercise price |
$15.41 |
Stock price |
$2.13 |
The key inputs used in the valuation were as follows:
|
|
|
|
|
|
Expected term (years) |
4.3 |
Expected volatility |
117.5 |
% |
Expected dividend rate |
— |
% |
Risk free rate |
4.4 |
% |
Estimated fair value per warrant |
$1.14 |
Exercise Price |
$14.93 |
Stock Price |
$2.13 |
The key inputs used in the valuation were as follows:
|
|
|
|
|
|
Expected term (years) |
4.6 |
Expected volatility |
117.5 |
% |
Expected dividend rate |
— |
% |
Risk free rate |
4.3 |
% |
Estimated fair value per warrant |
$ |
1.20 |
|
Exercise price |
$ |
15.41 |
|
Stock price |
$ |
2.13 |
|
The key inputs used in the valuation were as follows:
|
|
|
|
|
|
|
|
Expected term (years) |
4.3 |
Expected volatility |
117.5 |
% |
Expected dividend rate |
— |
% |
Risk free rate |
4.4 |
% |
Estimated fair value per warrant |
$ |
1.19 |
|
Exercise price |
$ |
12.91 |
|
Stock price |
$ |
2.13 |
|
The key inputs used in the valuation were as follows:
|
|
|
|
|
|
|
|
Expected term (years) |
4.8 |
Expected volatility |
117.5 |
% |
Expected dividend rate |
— |
% |
Risk free rate |
4.3 |
% |
Estimated fair value per warrant |
$ |
1.74 |
|
Exercise price |
$ |
2.24 |
|
Stock price |
$ |
2.13 |
|
|
Schedule of Fair Value of Convertible Debt and Earnout Shares Liability |
Following is a summary of the change in fair value of the Convertible Debt for the six months ended June 30, 2024 and June 30, 2023 (in thousands).
|
|
|
|
|
|
|
|
|
|
|
|
|
Six months ended June 30, |
Convertible Debt |
2024 |
|
2023 |
Beginning fair value |
$ |
16,052 |
|
|
$ |
— |
|
Additions during the period |
46,894 |
|
|
— |
|
Payments in cash and common stock during the period |
(57,241) |
|
|
— |
|
Change in fair value during the period |
41,523 |
|
|
— |
|
Ending fair value |
$ |
47,228 |
|
|
— |
|
Following is a summary of the change in fair value of the Earnout Shares liability for the six months ended June 30, 2024 and June 30, 2023 (in thousands).
|
|
|
|
|
|
|
|
|
|
|
|
|
Six months ended June 30, |
Earnout Shares Liability |
2024 |
|
2023 |
Beginning fair value |
$ |
41 |
|
|
$ |
3,013 |
|
|
|
|
|
Change in fair value during the period |
(41) |
|
|
(2,564) |
|
Ending fair value |
$ |
— |
|
|
$ |
449 |
|
|
Schedule of Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation |
|
|
|
|
|
|
|
|
|
|
|
|
|
Six months ended June 30, |
Derivative liability |
2024 |
|
2023 |
Beginning fair value |
$ |
26,779 |
|
|
$ |
— |
|
Additions during the period |
24,857 |
|
|
— |
|
Derecognition of liability upon expiration of agreement |
(1,604) |
|
|
— |
|
Change in fair value during the period |
(16,790) |
|
|
4,359 |
|
Ending fair value |
$ |
33,242 |
|
|
$ |
4,359 |
|
|